Research ArticleNuclear Oncology
Fluorine-18-Fluorouracil to Predict Therapy Response in Liver Metastases from Colorectal Carcinoma
Antonia Dimitrakopoulou-Strauss, Ludwig G. Strauss, Peter Schlag, Peter Hohenberger, Markus Mühler, Franz Oberdorfer and Gerhard van Kaick
Journal of Nuclear Medicine July 1998, 39 (7) 1197-1202;
Antonia Dimitrakopoulou-Strauss
Ludwig G. Strauss
Peter Schlag
Peter Hohenberger
Markus Mühler
Franz Oberdorfer


This is a PDF-only article. The first page of the PDF of this article appears above.
In this issue
Fluorine-18-Fluorouracil to Predict Therapy Response in Liver Metastases from Colorectal Carcinoma
Antonia Dimitrakopoulou-Strauss, Ludwig G. Strauss, Peter Schlag, Peter Hohenberger, Markus Mühler, Franz Oberdorfer, Gerhard van Kaick
Journal of Nuclear Medicine Jul 1998, 39 (7) 1197-1202;
Jump to section
Related Articles
- No related articles found.
Cited By...
- Absolute Quantification of [11C]docetaxel Kinetics in Lung Cancer Patients Using Positron Emission Tomography
- Estimation of Paclitaxel Biodistribution and Uptake in Human-Derived Xenografts In Vivo with 18F-Fluoropaclitaxel
- Prognostic Aspects of 18F-FDG PET Kinetics in Patients with Metastatic Colorectal Carcinoma Receiving FOLFOX Chemotherapy
- Kinetic Modeling of 5-Fluorouracil Anabolism in Colorectal Adenocarcinoma: A Positron Emission Tomography Study in Rats
- 18F-FDG PET Evaluation of the Response to Therapy for Lymphoma and for Breast, Lung, and Colorectal Carcinoma
- Enzyme Inhibition as an Aid to Simplify Pharmacokinetic Measurements?
- Blocking Catabolism with Eniluracil Enhances PET Studies of 5-[18F]Fluorouracil Pharmacokinetics